Oliver Bleck is currently the Area Head of Europe South at Roche, where they focus on enabling health innovation to improve patients' lives. Previously, they practiced as an MD, which reinforced their commitment to medical innovation. Oliver has held various leadership roles at Genentech, including Life Cycle Leader and Franchise Director for Avastin and MabThera/Rituxan. They have also contributed to Roche in multiple capacities, such as General Manager for Roche Pharma Switzerland and Franchise Head for oncology products. Oliver's extensive background in both clinical practice and pharmaceutical management highlights their dedication to enhancing healthcare through innovation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices